Michael Mallory

10PUBLICATIONS
131CO-AUTHORS
Genetic immunologyFish pests and diseasesMedical molecular engineering of nucleic acids and proteinsInnate immunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 25, 2026
Bile and capsid variation coregulate histo-blood group antigen recognition and serum neutralization potency in GII.12 human norovirus.

|Jul 08, 2026
Epidemiology and molecular evolution of norovirus GII.17 in the United States, 2021-2025.

|Mar 27, 2026
One-component ionizable amphiphilic Janus dendrimers as a delivery platform for efficient mRNA vaccine development.

Nathan A Ona, Dapeng Zhang, Lisa C Lindesmith

|Mar 05, 2025
Broadly neutralizing antibodies targeting pandemic GII.4 variants or seven GII genotypes of human norovirus.

Juyeon Park, Lisa C Lindesmith, Adam S Olia

|Jun 12, 2024
COVID-19 point-of-care tests can identify low-antibody individuals: In-depth immunoanalysis of boosting benefits in a healthy cohort.

Michael Mallory, Jennifer E Munt, Tara M Narowski

|May 22, 2024
The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronaviruses.

David R Martinez, Fernando R Moreira, Nicholas J Catanzaro

Pageof 2

Frequent Collaborators

10 joint publications

Ralph S Baric

7 joint publications

Lisa Lindesmith

3 joint publications

Mark Zweigart

2 joint publications

John M Powers